Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

Share Price is delayed by 15 minutes
Get Live Data
73.90    1.50 (2.07%)
Bid:
73.70
Ask:
74.20
Spread: 0.50 (0.678%)
Market Cap: £707.29m
DOCS Live PriceLast checked at - London Stock Exchange

Intraday Dr. Martens Share Chart

Technical change in Permira ownership structure

12 Jun 2024 16:35

RNS Number : 2034S
Dr. Martens PLC
12 June 2024
 

 

12 June 2024

Dr. Martens plc

Technical change in Permira ownership structure

 

Dr. Martens plc ('the Company') makes this announcement in connection with the TR-1 announcements released today regarding the notification of major holdings by IngreGrsy Limited and IngreLux S.àr.l..

Permira V Fund has undergone a restructure of its holding of shares in Dr. Martens plc, whereby IngreGrsy Limited (a newly incorporated Guernsey company) has replaced IngreLux S.àr.l. (a Luxembourg entity) in the Permira Fund V structure and IngreLux S.àr.l has transferred its 38.46% shareholding in the Company to IngreGrsy Limited.  As a result, IngreGrsy Limited replaced IngreLux S.àr.l. as the Company's largest shareholder with effect from 11 June 2024. The Company, IngreLux S.àr.l. and IngreGrsy Limited also entered into a novation agreement in order for IngreGrsy Limited to replace IngreLux S.à r.l. in the relationship agreement with the Company. The Permira V Fund ownership structure is otherwise unchanged and remains ultimately controlled by Permira V GP Limited and advised by Permira Advisers LLP.

 

 

Enquiries

Investors and analysts

Bethany Barnes, Director of Investor Relations Bethany.Barnes@drmartens.com +44 7825 187465

Beth Callum, Investor Relations Manager Beth.Callum@drmartens.com +44 203 995 2644

 

Company Secretariat

Paul Rolling, Assistant Company Secretary Paul.Rolling@drmartens.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKBBNPBKDBAD
Date   Source Headline
16th Nov 20237:00 amRNSChief Brand Officer Appointment
15th Nov 20236:13 pmRNSTransaction in Own Shares
14th Nov 20235:58 pmRNSTransaction in Own Shares
14th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSCFO Appointment
13th Nov 20236:06 pmRNSTransaction in Own Shares
10th Nov 20236:24 pmRNSTransaction in Own Shares
9th Nov 20236:03 pmRNSTransaction in Own Shares
8th Nov 20235:56 pmRNSTransaction in Own Shares
7th Nov 20236:23 pmRNSTransaction in Own Shares
6th Nov 20236:23 pmRNSTransaction in Own Shares
3rd Nov 20236:03 pmRNSTransaction in Own Shares
2nd Nov 20236:15 pmRNSTransaction in Own Shares
2nd Nov 20237:00 amRNSBlock listing application
1st Nov 20236:02 pmRNSTransaction in Own Shares
1st Nov 20233:47 pmRNSTotal Voting Rights
24th Oct 20235:38 pmRNSTransaction in Own Shares
23rd Oct 20236:19 pmRNSTransaction in Own Shares
20th Oct 20235:49 pmRNSTransaction in Own Shares
19th Oct 20235:55 pmRNSTransaction in Own Shares
18th Oct 20235:40 pmRNSTransaction in Own Shares
17th Oct 20236:00 pmRNSTransaction in Own Shares
16th Oct 20236:19 pmRNSTransaction in Own Shares
13th Oct 20235:16 pmRNSTransaction in Own Shares
12th Oct 20236:27 pmRNSDirector/PDMR Shareholding
12th Oct 20236:07 pmRNSTransaction in Own Shares
11th Oct 20236:24 pmRNSTransaction in Own Shares
10th Oct 20236:24 pmRNSTransaction in Own Shares
9th Oct 20235:37 pmRNSTransaction in Own Shares
6th Oct 20236:23 pmRNSTransaction in Own Shares
5th Oct 20236:21 pmRNSTransaction in Own Shares
4th Oct 20236:12 pmRNSTransaction in Own Shares
3rd Oct 20235:48 pmRNSTransaction in Own Shares
2nd Oct 20236:20 pmRNSTransaction in Own Shares
28th Sep 20235:36 pmRNSTransaction in Own Shares
27th Sep 20236:21 pmRNSTransaction in Own Shares
26th Sep 20235:55 pmRNSTransaction in Own Shares
25th Sep 20235:50 pmRNSTransaction in Own Shares
22nd Sep 20236:13 pmRNSTransaction in Own Shares
21st Sep 20236:18 pmRNSTransaction in Own Shares
20th Sep 20236:14 pmRNSTransaction in Own Shares
19th Sep 20235:47 pmRNSTransaction in Own Shares
18th Sep 20236:23 pmRNSTransaction in Own Shares
15th Sep 20236:20 pmRNSTransaction in Own Shares
14th Sep 20236:21 pmRNSTransaction in Own Shares
14th Sep 20237:00 amRNSProduct and Brand teach-in event
13th Sep 20236:23 pmRNSTransaction in Own Shares
12th Sep 20236:14 pmRNSTransaction in Own Shares
12th Sep 20235:07 pmRNSDirector/PDMR Shareholding
12th Sep 20234:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.